Literature DB >> 23611202

Determining the cutoff based on a continuous variable to define two populations with application to vaccines.

Shu Li1, Milton Parnes, Ivan S F Chan.   

Abstract

In clinical research, it is sometimes desirable to dichotomize a continuous variable so that the information expressed using a dichotomous variable is more straightforward for clinicians to interpret and communicate with patients. The distribution of the continuous variable can differ between two populations defined by a disease case status. Under such a scenario, the dichotomization process can be based on distributions of the continuous variable in two distinct populations. The resulting dichotomous variable can be used as an endpoint in future studies. Even though dichotomization has not been extensively studied, dichotomization has been commonly carried out in clinical trials. We developed a methodology for determining the optimal cutoff point based on maximizing the correlation between the two populations and the dichotomous variable. In some real-world scenarios where outcome status in samples from two populations is not completely identified, we recommend using EM method to first estimate the parameters associated with the two populations before applying the proposed method to find the optimal cutoff point. In addition, we have investigated the performance of the proposed method for several common distributions (e.g., normal, log-normal and exponential distribution) of the continuous variable. Finally, we applied the proposed methods to a varicella vaccine example.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23611202     DOI: 10.1080/10543406.2012.756502

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  3 in total

1.  Hemagglutination Inhibition Antibody Titers as a Correlate of Protection Against Seasonal A/H3N2 Influenza Disease.

Authors:  Anne Benoit; Jiri Beran; Jeanne-Marie Devaster; Meral Esen; Odile Launay; Geert Leroux-Roels; Janet E McElhaney; Lidia Oostvogels; Gerrit A van Essen; Manjusha Gaglani; Lisa A Jackson; Timo Vesikari; Catherine Legrand; Fabian Tibaldi; Bruce L Innis; Walthère Dewé
Journal:  Open Forum Infect Dis       Date:  2015-05-14       Impact factor: 3.835

Review 2.  Clinicopathological and prognostic significance of long non-coding RNA EWSAT1 in human cancers: A review and meta analysis.

Authors:  Jian Wen; Haima Li; Dongdong Li; Xieping Dong
Journal:  PLoS One       Date:  2022-03-14       Impact factor: 3.240

3.  Some extensions in continuous models for immunological correlates of protection.

Authors:  Andrew J Dunning; Jennifer Kensler; Laurent Coudeville; Fabrice Bailleux
Journal:  BMC Med Res Methodol       Date:  2015-12-28       Impact factor: 4.615

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.